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Abstract
Purpose Continuous positive airway pressure (CPAP) is the
gold standard treatment for obstructive sleep apnea. However,
the physiologic impact of CPAP on cerebral blood flow (CBF)
is not well established. Ultrasound can be used to estimate
CBF, but there is no widespread accepted protocol. We studied
the physiologic influence of CPAP on CBF using a method
integrating arterial diameter and flow velocity (FV) measure-
ments obtained for each vessel supplying blood to the brain.
Methods FVand lumen diameter of the left and right internal
carotid, vertebral, and middle cerebral arteries were measured
using duplex Doppler ultrasound with and without CPAP at
15 cmH2O, applied in a random order. Transcutaneous carbon
dioxide (PtcCO2), heart rate (HR), blood pressure (BP), and
oxygen saturation were monitored. Results were compared
with a theoretical prediction of CBF change based on the
effect of partial pressure of carbon dioxide on CBF.
Results Data were obtained from 23 healthy volunteers
(mean±SD; 12 male, age 25.1±2.6 years, body mass index
21.8±2.0 kg/m2). Themean experimental and theoretical CBF
decrease under CPAP was 12.5 % (p<0.001) and 11.9 %
(p<0.001), respectively. The difference between experimental
and theoretical CBF reduction was not statistically significant
(3.84±79 ml/min, p00.40). There was a significant reduction
in PtcCO2 with CPAP (p0<0.001) and a significant increase
in mean BP (p00.0017). No significant change was observed
in SaO2 (p00.21) and HR (p00.62).
Conclusion Duplex Doppler ultrasound measurements of ar-
terial diameter and FVallow for a noninvasive bedside estima-
tion of CBF. CPAP at 15 cm H2O significantly decreased CBF
in healthy awake volunteers. This effect appeared to be medi-
ated predominately through the hypocapnic vasoconstriction
coinciding with PCO2 level reduction. The results suggest that
CPAP should be used cautiously in patients with unstable
cerebral hemodynamics.
Keywords Continuous positive airway pressure . Cerebral
blood flow . PCO2 . Ultrasound
Introduction
Obstructive sleep apnea syndrome (OSAS) is characterized
by repetitive episodes of upper airway obstruction during
sleep and results in cessation (apneas) or reduction (hypo-
pneas) in airflow which leads to awakening and the reduc-
tion of blood oxygen saturation (SaO2). The most widely
accepted treatment of OSAS is continuous positive airway
pressure (CPAP). CPAP acts as a pneumatic “splint” by
producing a positive pressure inside the airway thereby
preventing upper airway collapse during sleep. Considering
that a rise in intrathoracic pressure increases jugular venous
pressure, CPAP could have an effect on cerebral blood flow
(CBF) by reducing the cerebral perfusion pressure [1, 2].
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Moreover, decreased venous return due to increased intra-
thoracic pressure may decrease right (and left) filling pres-
sure, which may in turn decrease cardiac output. CPAP use
can also induce changes in partial pressure of carbon diox-
ide (PCO2), which has a major impact on CBF, similar to the
way in which hypocapnia constricts cerebral arteries and
hypercapnia leads to a marked rise of CBF [3–5]. Changes
in CBF induced by CPAP may have important clinical
implications in patients for whom an optimal CBF is man-
datory, such as acute stroke patients.
Published data about the effects of CPAP on cerebral
hemodynamics are conflicting [6–8]. Various studies have
reported an increase [8, 9], others a decrease [7, 10], and
some an insignificant change [6] in CBF. The conflicting
results may be due to inaccurate and/or insensitive CBF
measurement methods. Furthermore, many of the studies
that employed transcranial Doppler ultrasound (TCD) used
only flow velocity (FV) and pulsatility index (PI) in the
middle cerebral artery (MCA) to estimate total CBF
[6–10]. However, TCD measurements do not take into ac-
count changes in artery diameter or in cerebral posterior
circulation. As a result, it is unclear whether changes in
MCA FV accurately reflect total CBF change. A method
that takes into account both blood FV and the artery diam-
eter of all vessels supplying blood to the brain is likely to be
more accurate. Furthermore, in the previous studies [6–8]
only end-tidal CO2 level was monitored. This is an inaccu-
rate measurement technique under the presence of CPAP
considering that the expired CO2 is diluted by incoming
CO2-free CPAP airflow.
The present study was performed to assess the effect
of CPAP on total CBF measured by duplex color Dopp-
ler ultrasound (US) using a method, similar to that pre-
sented by Schoning et al. [11], incorporating FV and
lumen diameter measurements obtained at the left and
right internal carotid artery (ICA), vertebral artery (VA),
and MCA. These measurements were obtained while
transcutaneous carbon dioxide (PtcCO2) level was moni-
tored continuously.
Methods
Healthy, young, nonsmoking volunteers were invited to
participate in the study by advertisement at the Centre
Hospitalier Universitaire Vaudois and École Polytechni-
que Fédérale de Lausanne in Switzerland. Volunteers
with a history of pulmonary, cardiac or cerebral disease
were excluded. The study was carried out in accordance
with the Declaration of Helsinki (1989) of the World
Medical Association and was approved by the local
ethics committee. All subjects gave their informed
consent.
Ultrasound measurements
The US measurements were performed with and without
CPAP (S8 AutoSet SpiritTM II, ResMed Inc, Poway, CA,
USA) applied at 15 cm H2O through a fitted full face mask
MIRAGE QUATTRO ® (ResMed®, ResMed Inc, Poway,
CA, USA) in a randomized order following a structured
protocol. Randomization was accomplished by flipping a
coin. The measurements were performed during the after-
noon at atmospheric pressure at least 2 h after the last meal
and drink with caffeine in a standard room with controlled
temperature. All volunteers, who were studied in the supine
position with a head tilt of 30°, tolerated CPAP at
15 cm H2O well. The arteries were studied with and without
CPAP in the following order: (a) right proximal ICA and
VA, (b) left proximal ICA and VA, and (c) right and left
MCA.
Peak systolic and end-diastolic FV and arterial diameter
were obtained in M-mode [12] for three time points at the
left and right ICA and VA using a 5–8 MHz duplex probe
(Echograph Acuson Sequoia 512). Only FV was studied at
the MCAs using a 2–4 MHz-pulsed TCD probe of the same
manufacturer. PtcCO2 level was monitored with a “Tosca
500” system (Radiometer Basel AG, Basel, Switzerland)
using a single sensor applied to the chest. SaO2 and heart
rate (HR) were monitored with a finger pulseoximeter
(Ohmeda) during the measurement period. Blood pressure
(BP) was recorded before and after each test. US measure-
ments under CPAP began after the PtcCO2 level returned to
baseline (±2 mmHg) or at steady state after at least 15 min of
CPAP use. This time period was sufficient to ensure a steady
state as changes in CBF caused by an alteration in PCO2
level have been found to be completed within 30 s[13].
CBF calculations
A single investigator (CO) performed all of the US exams
with the exception of two (LH). All velocity and diameter
measurements, based on the US images, were performed by
two investigators (CO, TY). Exams were reviewed by both
investigators to assure that measurements were performed
on the same M-mode screen and on the correct vessel within
the region of interest. The mean value of both investigators’
measurements was used for the calculations. The mean FV
in each vessel was calculated by measuring the peak systol-
ic, FVsys, and end diastolic, FVdia, FV for three cardiac
cycles (Eq. 1)
FV ¼ FVsysþ2FVdia
3
ð1Þ
Mean diameter D of each vessel for three cardiac cycles
was calculated based on the M-mode US measurements [12]
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using a similar equation as Eq. 1, except with FV replaced
with the systolic and diastolic diameter. An example of the
FV and diameter measurement obtained at the right ICA is
shown in Fig. 1.
Flow rate, Q (millimeter per minute), in each vessel was
calculated by (Eq. 2) and total experimental CBF, CBFexp,
was determined by the sum of the flow in the left and right
ICAs and VAs assuming a parabolic velocity profile[14]
(Eq. 3).
Q ¼ FV
2
 pD
2
4
ð2Þ
CBFexp ¼ QICAs þ QVAs ð3Þ
Vascular related results are presented as the average of
the left and right vessel measurements for the 23 subjects
(i.e., FVICA ¼ 123
P23
n¼1
ðFVICAleft þ FVICArightÞ=2).
The following method was used to predict a theoretical
change in CBF given an experimentally measured change in
PtcCO2 level. The relationship between CBF (ml/min/100 g
brain tissue) and arterial CO2 tension (millimeters of mercury)
has been quantified in the literature (Fig. 2) [3, 15–21]. Table 1
summarizes the slope of the CBF to PCO2 curve at baseline
PCO2 level based on Fig. 2 and other studies in the literature.
The average slope was calculated to be 1.65, with a maximum
and minimum slope value of 3.20 and 0.19, respectively (stan-
dard deviation00.92). The average slope was used to determine
a theoretical reduction in CBF in ml/min/100 g of brain tissue,
ΔCBFtheor100, based on the experimentally measured change in
PtcCO2 level with and without CPAP ΔCBFtheor100 ¼
slopeΔPtcCO2. The total theoretical change in CBF was
determined (ΔCBFtheor ¼ 14ΔCBFtheor100 ) assuming that
the human brain is approximately 14 times the weight of a
Rhesus monkey [21].
The CBFexp measurements were used to determine the
experimental CBF reduction (ΔCBFexp). Positive CBF reduc-
tion values were defined to indicate that total CBF decreased
under CPAP, and vice versa. The average and standard devi-
ation ofΔCBFexp and ΔCBFtheor were determined for the 23
subjects based on both investigators measurements.
Statistical analysis
Statistical analysis was conducted with STATA software
(version 11; College Station, TX, USA). The variable mea-
sured parameters were compared between conditions using
a two-tailed paired t test and Mann–Whitney test, where
appropriate. The level of significance was set at 95 %.
Multivariate logistic regression, limited to two variables
according to the total number of subjects, was performed
with predictors with a univariate result of p<0.1. Agreement
between investigators was calculated with the Lin’s concor-
dance correlation coefficient for agreement on a continuous
measure.
Results
The study group was comprised of 23 subjects (12 male, 11
female) aged from 20 to 30 years (mean±SD; 25.1±
2.6 years) with a mean body mass index (BMI) of 21.8±
2.04 kg/m2. Thirteen volunteers began the randomized mea-
surement protocol with CPAP. Table 2 shows a summary of
the hemodynamic data and results for the CBF calculations
with and without CPAP.
With CPAP, FV decreased significantly in the ICA (0.05±
0.05 m/s, p00.0002) and the MCA (0.038±0.06 m/s, p0
0.009), but not significantly at the VA (0.009±0.04 m/s, p0
0.25). Decrease in the ICA diameter was insignificant (−0.06±
0.2 mm, p00.14), while decrease in VA diameter was signif-
icant (−0.12±0.12 mm, p<0.001). In a multivariate robust
regression, with total CBF reduction as a dependant variable,
only ICA FV (p<0.001) remained significant, whereas MCA
FV was not significant (p00.21).
A significant reduction in PtcCO2 under CPAP (2.6±
2.4 mm Hg, p0<0.001) and an increase in mean BP (2.7±
3.6 mm Hg, p00.0017) were measured. No significant
change in SaO2 (0.4±1.6 %, p00.21) and HR (0.9565±
7.3173, p00.62) was measured. Figure 3 illustrates the total
CBFexp reduction compared to the CBFtheor reduction for
each of the 23 subjects and the average reduction for the
entire study.
The mean CBFexp decreased under CPAP by 12.5 %
(66.6±63 ml/min, p<0.001), while the mean decrease in
CBFtheor was 11.9 % (62.8±54.4 ml/min, p<0.001). There
was no significant difference between experimental and
theoretical CBF reduction (3.84±79 ml/min, p00.40). No
difference was found according to the sequence of measure-
ments with or without CPAP, gender, height, weight, or
BMI. No significant differences were found also between
the left and right side US measurements of each arterial
vessel. Agreement between final investigators results for
CBF reduction in every subject was 87 % (95 % confidence
interval 0.73–0.97).
Discussion
We observed that CPAP applied at 15 cm H2O significantly
decreased the total CBF in healthy awake volunteers. The
change in CBF was studied using a method that integrates
ultrasound measurements of blood FV and arterial lumen
diameter obtained at the left and right ICA, VA, and MCA.
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Previous studies measured FV and PI in the MCA with
the hypothesis that these parameters were a good indicator
of total CBF [6–10]. Thus, the arterial diameter was as-
sumed to remain stable [4]. Table 3 summarizes the main
technical characteristics and results of the previous studies
that investigated the effect of CPAP on CBF hemodynamics.
We chose to evaluate total CBF based on the arterial diam-
eter and FV measured in each of the primary vessels that
supply blood to the brain (ICAs and VAs). Measurement of
diameter and FV in these vessels has been proposed to be a
more accurate and detailed method to help estimate total
CBF [22].
In our study, we chose to monitor PCO2 transcutaneously
because it avoids the confounding dilution effect of end-tidal
CO2 measurements that occurs due to the mixing of expired
CO2 with incoming CO2-free CPAP airflow. However, end-
tidal PCO2 monitoring has also several advantages, such as
the quick response under provocative conditions as well as the
fact it provides detailed information about the breathing pat-
tern (i.e., respiratory rate). In the case of end-tidal PCO2
monitoring, the problem of CO2 dilution in the mask under
CPAP could be avoided by the insertion of a thin catheter into
one nostril far from the expiratory port [7, 23].
The underlying physiological mechanism that results in
CBF change due to CPAP usage is complex. A CPAP-
induced increase in intrathoracic pressure may provoke he-
modynamic effects (i.e., reduced cardiac output, reduced
venous return, increased cerebral venous pressure) that
could result in a decrease of cerebral perfusion pressure
and CBF. On the other hand, it is well accepted that PCO2
Fig. 1 Flow velocity (a) and
vessel diameter in M-mode ul-
trasound (b) measured at the
right ICA
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affects the muscular regulation of the arterial wall, with
hypercapnia leading to vasodilatation and hypocapnia to
vasoconstriction. The relative contribution of CPAP-
induced changes, such as intrathoracic pressure and PCO2
level, to CBF change is unknown.
Our results supported that CBF reduction due to CPAP
usage was primarily mediated through hypocapnic vasocon-
striction. CPAP-induced intrathoracic pressure and venous
hemodynamic changes did not appear to play an important
role in CBF reduction. To determine the theoretical CBF
effect of variation in PCO2 level with and without CPAP, we
used the average value of the slope of the CBF responsive-
ness to acute change in PCO2 reported in the literature
(Table 1). The difference between the theoretically predicted
and experimentally measured change in CBF was not found
to be significant (Fig. 3). This suggests that the theoretical
prediction of the CBF decrease, which takes into account
only the monitored PtcCO2 level, was sufficient to capture
the CBF changes that were observed. Thus, an increase in
intrathoracic pressure alone did not appear to play a signif-
icant role in CBF alteration.
This study cannot conclude if CPAP pressure had a direct
impact on total CBF. This is because the statistical calcula-
tion used to determine that intrathoracic pressure increase
did not have a significant impact on total CBF was critically
dependent on the assumed slope for change in CBF to PCO2
level. Awide range of slope values have been reported in the
literature (Table 1, slope00.19–3.20) and thus it is possible
that the theoretical predictions over or underestimated CBF
change. For example, if the slope used to determine the
theoretical change in CBF was chosen to be <1.1, the impact
of CPAP pressure would have been found to be significant.
Table 1 Summary of CBF to PCO2 slopes reported in the literature for
different animal types and CBF measurement techniques (N2O nitrous
oxide, NO nitric oxide, Kr85 radioactive krypton, H2
15O transit diffus-
ible tracer), Cerebral venous flowmeter (CVF), Intraarterial 133Xe
Investigator Animal type CBF
measurement
technique
Slope
(ΔCBF=ΔPCO2)
at baseline PCO2
Kety [15] Man N2O 1.47
Markwalder [3] Man Doppler 3.12
Wasserman [17, 30] Man N2O 2.17
Eng [19] Man NO 3.20
Henriksen [20] Man 133Xe 1.36
White [31],
Lambertsen [32]
Man N2O 1.34
Alexander [33] Man Kr85 1.06
Pierce [34] Man N2O 0.43
Grubb [17] Monkey H2
15O 1.80
Reivich [21] Monkey Thermistor
Flowmeter
1.11
White [31] Monkey CVF 1.11
Harper [16] Dog Kr85 2.69
Raichle [37] Dog Kr85 0.90
Fujishima [38] Dog N2O 0.19
Smith [36] Goat Kr85 1.79
James [35] Baboon Kr85 1.22
Wang [18] Rat NO 3.10
Ave 1.65
Max 3.20
Min 0.19
SD, 0.92
Fig. 2 Relation for change in CBF (ml/min/100 g brain tissue) given a
change in PCO2 (mm Hg) based on studies in the literature [3, 15–21]
Table 2 Hemodynamic results for the 23 volunteers with and without
CPAP. All values are expressed as mean (SD)
No CPAP (SD) CPAP (SD) p Value
BP (mmHg) 87.3 (6.6) 90 (7.1) 0.0017
HR 68.8 (10.6) 69.7 (12) 0.62
PtcCO2 (mm Hg) 36.3 (5.3) 33.7 (6.2) <0.001
SaO2 (%) 97.5 (1.2) 97.9 (1.3) 0.21
FVICA (m/s) 0.48 (0.07) 0.43 (0.06) 0.0002
FVVA (m/s) 0.31 (0.05) 0.30 (0.05) 0.25
FVMCA (m/s) 0.65 (0.12) 0.62 (0.12) 0.009
PIICA 0.98 (0.18) 0.97 (0.22) 0.76
PIVA 1.20 (0.18) 1.21 (0.18) 0.92
PIMCA 0.78 (0.1) 0.82 (0.1) 0.12
DICA (mm) 4.13 (0.6) 4.07 (0.6) 0.14
DVA (mm) 2.98 (0.4) 2.85 (0.4) <0.001
CBF (ml/min) 535 (122.1) 468.5 (105.6) <0.001
CPAP continuous positive airway pressure, BP blood pressure, HR
heart rate, PtcCO2 transcutaneous carbon dioxide level, SaO2 oxygen
saturation, FV flow velocity, PI pulsatility index, D diameter, CBF
cerebral blood flow, SD standard deviation
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To better understand the impact, if any, of intrathoracic
pressure alterations brought on by CPAP usage on CBF, a
study would need to be conducted with the PCO2 level held
constant while CPAP pressure is altered incrementally.
It appears that CPAP may decrease total CBF in
healthy awake volunteers indirectly by modulating the
PCO2 level. However, the physiological mechanism for
decrease of PCO2 under CPAP is unclear. Our findings
show a significant increase in BP under CPAP. This may
be due to the autoregulation of systemic BP which seeks
to maintain stable CBF [24]. Similarly, SaO2 in the
healthy range has little effect on the radius of blood
vessels and subsequently on CBF [25]. One hypothesis
for the change in total CBF is that CPAP improves the
lung perfusion/ventilation ratio, which may increase CO2
washout. Another explanation could be that the subjects
experienced a mild hyperventilation due to anxiety in-
duced by breathing against the CPAP. In our study, anx-
iety was not measured, but our measurements were
obtained after an acclimatization period. It is also possible
that anxiety had a direct influence on CBF.
Changes in CBF induced by CPAP could have important
clinical implications in patients requiring an optimal and
stable CBF such as acute stroke patients. The question of
CPAP use in early stroke patients with OSAS remains open
considering the positive effect of CPAP on apnea-induced
oxygen deprivation versus possible negative effects of CPAP,
such as reduction of total CBF. A specific study would need to
be performed to examine the impact of CPAP pressure on
CBF in stroke patients to validate these conjectures.
A primary limitation of this study is that the subjects who
were tested were both healthy and awake. Subjects who are
awake may react differently to CPAP than sleeping OSAS
patients. However, these measurements could not be
obtained on sleeping subjects, as these measurements would
awaken them, and variable comorbidities (e.g., obesity,
heart failure, medication) would make comparison between
the subjects’ results unreliable. Furthermore, our results
Fig. 3 Comparison of the total
CBF reduction (millimeter per
minute) under CPAP, ΔCBFexp,
with the predicted theoretical
reduction in CBF, ΔCBFtheor,
for each of the 23 subjects (left)
and the average value for CBF
reduction in all subjects (right)
Table 3 Summary of the main technical features of the studies in the literature that investigated the impact of CPAP on CBF hemodynamics
Investigator Level of CPAP
( cm H2O)
No of subjects/
health condition
Position of the
subject/type of
CPAP mask
US
measurement
technique
CBF measurement
technique
PCO2
measurement
Hemodynamic
monitoring
Results
Bowie et al. [6] 5, 10 15 awake/healthy Supine/mouthpiece TCD FV on MCA End-tidal CO2 BP No significant
change
Scala et al. [7] 5, 10, 15 25 awake/healthy Supine/mouthpiece TCD FV on MCA End-tidal CO2 BP, HR, RR,
SaO2, anxiety
score
Decrease of FV
Scala et al. [23] Auto-CPAP mode
(4–10) and
increasing
levels of
5, 10, 15
12 asleep and
awake/acute
stroke patients
Supine/nasal
or facial
TCD FV on MCA End-tidal CO2 BP, SaO2 Decrease
of FV
Haring et al. [8] 12 9 awake/healthy Supine/mouthpiece TCD FV on MCA End-tidal CO2 BP, HR Increase of FV
Present study 15 23 awake/healthy Supine/mouthpiece Duplex color
Doppler US
FV and lumen
diameter of
ICA, VA
and FV on
MCA
Transcutaneous
PtcCO2
BP, HR, SaO2 Decrease
of CBF
CPAP continuous positive airway pressure, BP blood pressure, HR heart rate, PtcCO2 transcutaneous carbon dioxide level, SaO2 oxygen saturation,
FV flow velocity, CBF cerebral blood flow, RR respiratory rate
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suggest that non-invasive techniques that could be con-
ducted during sleep, such as transcranial Doppler ultrasound
obtained at the MCAs, may not be sufficient to measure the
changes in CBF that were observed (Table 1). In our study,
measurement of FV and diameter at all vessels supplying
blood to the brain was needed to detect the CBF changes. In
a multivariate robust regression with total CBF reduction as
a dependent variable, only ICA FV remained significant.
From a clinical point of view, this result justifies the fact that
a bedside sampling of this parameter could more easily
approximate total CBF, something that could be less time
consuming especially in the case of patients such as acute
stroke patients or OSAS patients with ischemic encephalop-
athy. It would be very interesting for future studies to
examine this US approach on the aforementioned clinical
population.
A secondary limitation of this study is that even though
the assignment to spontaneous breathing or to CPAP was
based on a randomized order following a structured proto-
col, a "breathing-machine effect" could not be excluded
[26]. However, the protocol was set to evaluate the global
impact of the CPAP (mask in combination with pressurized
air) to cerebral hemodynamics as a mainstay therapy of
OSAS. To further understand the effect of the CPAP mask
and that of the CPAP mask and pressurized air using "sham
ventilation", a separate study should be conducted focused
on the potential effect of the mask itself on the breathing
pattern independently from the pressurized air.
Another limitation of this study is that CPAP was adjusted
at the high level of 15 cm H2O. Haring et al. [8] and Droste et
al. [27] submitted volunteers to CPAP 12 and 9 cm H2O,
respectively whereas Bowie et al. [6] and Scala et al. [7]
studied the effects of different and increasing levels of CPAP
on CBF. In our study, we applied CPAP of 15 cm H2O in
young healthy awake volunteers. This high level of CPAP is
rarely used in controlling patients with sleep disordered
breathing. CPAP at 15 cmH2O was useful in the experimental
setting of our study in order to underline the maximum phys-
iological effects of CPAP on cerebral hemodynamics by min-
imizing possible bias. The level of CPAP was set at
15 cm H2O on the machine. It is possible that this high
pressure could have resulted in substantial air leaks and
caused a gap between the applied and delivered mask pressure
and subsequently increased subject discomfort [28, 29]. How-
ever, during the ultrasound measurements of our study the
presence of air leaks was repeatedly assessed by the MD and
adjusted when needed. All volunteers tolerated well the mask
with CPAP at 15 cm H2O.
Another limitation of this study is due to the operator
dependence of the measurements used to determine CBF. To
minimize operator-dependent error, both operators that con-
ducted the vessel lumen measurements reviewed the US
images together after the measurements were made. This
review helped to assure that the correct vessel and the same
acquisition period were used for the diameter measure-
ments. With this precaution, a good agreement score was
found.
In addition to operator-dependent error, our study utilized
equations to calculate blood flow based on simplified hy-
drodynamics. To calculate total CBF, it was assumed that
zero phase delay occurred between the arrival of the FVsys at
the ICA and VA and that a parabolic velocity profile was
present to determine the true flow rate within the vessels
[14]. To minimize measurement error, the mean flow in each
vessel was approximated using the average of three sequen-
tial diastolic and systolic FV and diameter measurements.
Even with these simplifications, the presented methodology
is robust because it is sensitive to changes in CBF, the
measurement of which was the primary objective of this
study.
In conclusion, our study presents a noninvasive bedside
method to evaluate total CBF in awake subjects using CPAP
that could potentially be an improvement over other meth-
ods which only take into account FV at the MCA. The
results suggest that CPAP at 15 cm H2O significantly
decreases CBF in healthy, awake volunteers. This effect
seems to be mediated predominately through the hypo-
capnic vasoconstriction and likely, to a lesser extent,
through the direct effect of CPAP on intrathoracic pressure
and venous hemodynamics. These results suggest that
CPAP should be cautiously used in patients with unstable
cerebral hemodynamics.
Acknowledgments The authors are indebted to all volunteers whose
participation made this study possible. This study was funded by the
Swiss National Science Foundation Grant 205321_132695/1.
References
1. Buda AJ, Pinsky MR, Ingels NB Jr, Daughters GT 2nd, Stinson
EB, Alderman EL (1979) Effect of intrathoracic pressure on left
ventricular performance. N Engl J Med 301(9):453–459.
doi:10.1056/NEJM197908303010901
2. Becker H, Grote L, Ploch T, Schneider H, Stammnitz A, Peter JH,
Podszus T (1995) Intrathoracic pressure changes and cardiovascu-
lar effects induced by nCPAP and nBiPAP in sleep apnoea patients.
J Sleep Res 4(S1):125–129
3. Markwalder TM, Grolimund P, Seiler RW, Roth F, Aaslid R (1984)
Dependency of blood flow velocity in the middle cerebral artery on
end-tidal carbon dioxide partial pressure–a transcranial ultrasound
Doppler study. J Cereb Blood Flow Metab 4(3):368–372
4. Valdueza JM, Draganski B, Hoffmann O, Dirnagl U, Einhaupl KM
(1999) Analysis of CO2 vasomotor reactivity and vessel diameter
changes by simultaneous venous and arterial Doppler recordings.
Stroke 30(1):81–86
5. Eicke BM, Buss E, Bahr RR, Hajak G, Paulus W (1999) Influence
of acetazolamide and CO2 on extracranial flow volume and intra-
cranial blood flow velocity. Stroke 30(1):76–80
Sleep Breath (2013) 17:289–296 295
6. Bowie RA, O'Connor PJ, Hardman JG, Mahajan RP (2001) The
effect of continuous positive airway pressure on cerebral blood
flow velocity in awake volunteers. Anesth Analg 92(2):415–417
7. Scala R, Turkington PM, Wanklyn P, Bamford J, Elliott MW
(2003) Effects of incremental levels of continuous positive airway
pressure on cerebral blood flow velocity in healthy adult humans.
Clin Sci (Lond) 104(6):633–639. doi:10.1042/CS20020305
8. Haring HP, Hormann C, Schalow S, Benzer A (1994) Continuous
positive airway pressure breathing increases cerebral blood flow
velocity in humans. Anesth Analg 79(5):883–885
9. Klingelhofer J, Hajak G, Sander D, Schulz-Varszegi M, Ruther E,
Conrad B (1992) Assessment of intracranial hemodynamics in
sleep apnea syndrome. Stroke 23(10):1427–1433
10. Netzer N, Werner P, Jochums I, Lehmann M, Strohl KP (1998)
Blood flow of the middle cerebral artery with sleep-disordered
breathing: correlation with obstructive hypopneas. Stroke 29
(1):87–93
11. Schoning M, Walter J, Scheel P (1994) Estimation of cerebral
blood flow through color duplex sonography of the carotid and
vertebral arteries in healthy adults. Stroke: A Journal of Cerebral
Circulation 25(1):17–22
12. Harloff A, Strecker C, Reinhard M, Kollum M, Handke M,
Olschewski M, Weiller C, Hetzel A (2006) Combined measure-
ment of carotid stiffness and intima-media thickness improves
prediction of complex aortic plaques in patients with ischemic
stroke. Stroke 37(11):2708–2712
13. Tominaga S, Strandgaard S, Uemura K, Ito K, Kutsuzawa T (1976)
Cerebrovascular CO2 reactivity in normotensive and hypertensive
man. Stroke 7(5):507–510
14. Leguy CA, Bosboom EM, Hoeks AP, van de Vosse FN (2009)
Model-based assessment of dynamic arterial blood volume flow
from ultrasound measurements. Med Biol Eng Comput 47(6):641–
648. doi:10.1007/s11517-009-0473-9
15. Kety SS, Schmidt CF (1948) The effects of altered arterial tensions
of carbon dioxide and oxygen on cerebral blood flow and cerebral
oxygen consumption of normal young men. J Clin Invest 27
(4):484–492
16. Harper AM, Glass HI (1965) Effect of alterations in arterial carbon
dioxide tension on blood flow through cerebral cortex at normal
and low arterial blood pressures. J Neurol Neurosur Ps 28(5):449–
452
17. Grubb RL Jr, Raichle ME, Eichling JO, Ter-Pogossian MM (1974)
The effects of changes in PaCO2 on cerebral blood volume, blood
flow, and vascular mean transit time. Stroke 5(5):630–639
18. Wang Q, Paulson OB, Lassen NA (1992) Effect of nitric-oxide
blockade by N-G-nitro-L-arginine on cerebral blood-flow response
to changes in carbon-dioxide tension. J Cerebr Blood F Met 12
(6):947–953
19. Eng C, Lam A, Mayberg T, Mathison T, Lee C (1992) The
influence of propofol with and without nitrous-oxide on cerebral
blood-flow velocity and Co2 reactivity in man. Stroke 23(3):456–
456
20. Henriksen L (1986) Brain luxury perfusion during cardiopulmo-
nary bypass in humans—a study of the cerebral blood-flow re-
sponse to changes in Co2, O-2, and blood pressure. J Cerebr Blood
F Met 6(3):366–378
21. Reivich M (1964) Arterial Pco2 and cerebral hemodynamics. Am J
Physiol 206:25–35
22. Kontos HA (1989) Validity of cerebral arterial blood flow calcu-
lations from velocity measurements. Stroke 20(1):1–3
23. Scala R, Turkington PM, Wanklyn P, Bamford J, Elliott MW
(2009) Acceptance, effectiveness and safety of continuous positive
airway pressure in acute stroke: a pilot study. Respir Med 103
(1):59–66. doi:10.1016/j.rmed.2008.08.002
24. Schmidt JF, Waldemar G, Vorstrup S, Andersen AR, Gjerris F,
Paulson OB (1990) Computerized analysis of cerebral blood flow
autoregulation in humans: validation of a method for pharmaco-
logic studies. J Cardiovasc Pharmacol 15(6):983–988
25. Guyton AC (1991) Textbook of medical physiology, 8th edn.
Saunders, Philadelphia
26. Stroobant N, Vingerhoets G (2000) Transcranial Doppler ultraso-
nography monitoring of cerebral hemodynamics during perfor-
mance of cognitive tasks: a review. Neuropsychol Rev 10
(4):213–231
27. Droste DW, Ludemann P, Anders F, Kemeny V, Thomas M,
Krauss JK, Ringelstein EB (1999) Middle cerebral artery blood
flow velocity, end-tidal pCO(2) and blood pressure in patients with
obstructive sleep apnea and in healthy subjects during continuous
positive airway pressure breathing. Neurol Res 21(8):737–741
28. Navalesi P, Fanfulla F, Frigerio P, Gregoretti G, Nava S (2000)
Physiologic evaluation of noninvasive mechanical ventilation de-
livered with three types of masks in patients with chronic hyper-
capnic respiratory failure. Crit Care Med 28(6):1785–1790
29. Bakker JP, Neill AM, Campbell AJ (2011) Nasal versus oronasal
continuous positive airway pressure masks for obstructive sleep
apnea: a pilot investigation of pressure requirement, residual dis-
ease, and leak. Sleep Breath. doi:10.1007/s11325-011-0564-3
30. Wasserman A, Patterson JL (1961) Cerebral vascular response to
reduction in arterial carbon dioxide tension. J Clin Investig 40
(7):1297–1303
31. White JC, Brooks JR, Goldthwait JC, Adams RD (1943) Changes
in brain volume and blood content after experimental concussion.
Ann Surg 118(4):619–633
32. Lambertsen CJ, Owen SG, Wendel H, Stroud MW, Lurie AA,
Lochner W, Clark GF (1959) Respiratory and cerebral circulatory
control during exercise At.21 and 2.0 atmospheres inspired Po2. J
Appl Physiol 14(6):966–982
33. Alexander SC, Cohen PJ, Wollman H, Smith TC, Reivich M,
Vandermolen RA (1965) Cerebral carbohydrate metabolism during
hypocarbia in man: studies during nitrous oxide anesthesia. Anes-
thesiology 26:624–632
34. Pierce EC, Linde HW, Deutsch S, Chase PE, Price HL, Lambertsen
CJ, Dripps RD (1962) Cerebral circulation and metabolism during
thiopental anesthesia and hyperventilation in man. J Clin Investig
41(8):1664–1671
35. James IM, Millar RA, Purves MJ (1969) Observations on extrinsic
neural control of cerebral blood flow in baboon. Circ Res 25
(1):77–93
36. Smith AL, Neufeld GR, Ominsky AJ, Wollman H (1971) Effect of
arterial Co2 tension on cerebral blood flow, mean transit time, and
vascular volume. Journal of Applied Physiology 31(5):701–707
37. Raichle ME, Posner JB, Plum F (1970) Cerebral blood flow during
and after hyperventilation. Arch Neurol-Chicago 23(5):394–403
38. Fujishima M, Scheinberg P, Busto R, Reinmuth OM (1971) The
relation between cerebral oxygen consumption and cerebral vas-
cular reactivity to carbon dioxide. Stroke 2(3):251–257
296 Sleep Breath (2013) 17:289–296
